Cipla Ltd.

BSE: 500087 | NSE: CIPLA

Large Cap | Pharmaceuticals & Drugs

1438.75

-2.95 (-0.20%)

< Home < Back

Cipla informs about press release

Date: 12-11-2018

Cipla has informed about Press Release dated 12th November, 2018, titled ‘Cipla receives final approval for generic version of Roche’s Valcyte (Valganciclovir Tablets 450mg)’.

The above information is a part of company’s filings submitted to BSE.